[Organ-preserving treatment for urothelial carcinoma of the upper urinary tract].

IF 0.5 4区 医学 Q4 UROLOGY & NEPHROLOGY
Clemens M Rosenbaum, Christopher Netsch, Simon Filmar, Sophia Hook, Andreas J Gross, Benedikt Becker
{"title":"[Organ-preserving treatment for urothelial carcinoma of the upper urinary tract].","authors":"Clemens M Rosenbaum, Christopher Netsch, Simon Filmar, Sophia Hook, Andreas J Gross, Benedikt Becker","doi":"10.1007/s00120-024-02422-3","DOIUrl":null,"url":null,"abstract":"<p><p>Urothelial carcinoma of the upper urinary tract is rare but the incidence is currently increasing in western countries. Radical nephroureterectomy has long been the standard treatment; however, it can lead to chronic kidney failure and also the necessity for dialysis. Therefore, organ-preserving treatment is now recommended for selected patients with low-risk tumors. The choice of treatment depends on the tumor characteristics, comorbidities and individual risk factors. Surgical options for organ preservation include ureterorenoscopy (URS), percutaneous treatment and partial ureteral resection. The URS is the most frequently used method for organ preservation. Photodynamic diagnostics (PDD) and narrow band imaging (NBI) can potentially also be used for tumor detection in the upper urinary tract. Conservative options such as topical treatment with mitomycin C or Bacillus Calmette-Guérin (BCG) and systemic treatment options are also possible.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00120-024-02422-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Urothelial carcinoma of the upper urinary tract is rare but the incidence is currently increasing in western countries. Radical nephroureterectomy has long been the standard treatment; however, it can lead to chronic kidney failure and also the necessity for dialysis. Therefore, organ-preserving treatment is now recommended for selected patients with low-risk tumors. The choice of treatment depends on the tumor characteristics, comorbidities and individual risk factors. Surgical options for organ preservation include ureterorenoscopy (URS), percutaneous treatment and partial ureteral resection. The URS is the most frequently used method for organ preservation. Photodynamic diagnostics (PDD) and narrow band imaging (NBI) can potentially also be used for tumor detection in the upper urinary tract. Conservative options such as topical treatment with mitomycin C or Bacillus Calmette-Guérin (BCG) and systemic treatment options are also possible.

[上尿路尿路上皮癌的保留器官治疗]。
上尿路尿路上皮癌虽然罕见,但目前在西方国家的发病率却在不断上升。长期以来,根治性肾切除术一直是标准治疗方法,但它可能导致慢性肾功能衰竭,还必须进行透析。因此,目前建议对部分低风险肿瘤患者进行器官保留治疗。治疗方法的选择取决于肿瘤特征、合并症和个体风险因素。保留器官的手术选择包括输尿管镜检查(URS)、经皮治疗和输尿管部分切除术。输尿管镜检查是最常用的器官保留方法。光动力诊断(PDD)和窄带成像(NBI)也可用于上尿路肿瘤的检测。此外,还可以采用丝裂霉素 C 或卡介苗(BCG)局部治疗等保守治疗方案和全身治疗方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Urologie
Urologie UROLOGY & NEPHROLOGY-
CiteScore
1.00
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信